Industry News (Fetal Testing)

U.S. Launch of Fetal Genetic Testing Products Announced

Published in Women's Health Weekly, December 4th, 1995

Aprogenex Inc., Houston, Texas, is introducing two products for sale to researchers in the United States, which the company believes will expedite development and worldwide acceptance of a simple blood test to reduce the number of amniocentesis tests performed as a genetic screening procedure for pregnant mothers.

The two products, AproProbe and AproProbe Plus offer a new method of recognizing fetal cells and for identifying certain chromosome disorders. According to Dr. Luis Cantarero, chief operating officer of the company, "The products are much faster and simpler than any other method currently available."

Cantarero also said that AproProbe may...

Want to see the full article?

Purchase this article for only $3.00

We're a pay-per-view site for premium content. If you'd like to purchase this article, it's only $3.00.

Welcome to NewsRx!

Learn more about a six-week, no-risk free trial of Women's Health Weekly

Source: Women's Health Weekly (1995-12-04)

NewsRx is Social

Top Medical Newsletters

Awards

Best Health/Healthcare Content, 2012
Best Health/Healthcare Content, 2011
Best e-Business Site, 2010
Best e-Business Site, 2009
Best e-Business Site, 2008
Best e-Business Site, 2007
Best e-Business Site, 2006
Best Healthcare Content, 2005
Best Overall Internet Site, 2005
Best Interactive Site, 2005

Facts & Stats

NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.

Google 2010 PageRank: #2 Among Top Health News and Media Publications
Google 2010 PageRank: #2 Among Top Science Publications in Biology/Physiology
Google 2010 PageRank: #2 Among Top News and Media for the Business of Pharmaceuticals
Amazon's Alexa 2010 PageRank: #2 News and Media Site for the Pharmaceutical Industry